Robotic prostatectomy in Turkey: what it is and how it works
Robotic prostatectomy (also known as robot-assisted laparoscopic radical prostatectomy, or RARP) is a minimally invasive surgical procedure used to treat localized prostate cancer by removing the entire prostate gland, the seminal vesicles, and surrounding tissue. Rather than making a large pelvic incision, the surgeon makes five or six keyhole incisions across the lower abdomen. Through these ports, miniature surgical instruments and a high-definition 3D endoscope are inserted into the pelvic cavity. The operating surgeon sits at an ergonomic console beside the operating table, manipulating master controls that translate hand movements into microscopic, tremor-filtered actions inside the patient. Hospitals in Turkey perform this procedure using robotic surgical platforms such as the da Vinci system for men seeking surgical cancer management abroad.
Robotic prostatectomy is an oncological surgery designed to achieve complete tumour clearance while preserving, whenever clinically appropriate, the delicate neurovascular bundles responsible for urinary continence and erectile function. This guide explains how the robotic technology works, what clinical research confirms about cancer control, how approximate costs in Turkey compare with the UK, US, and Germany, what the surgical recovery involves, and how to verify hospital standards. For a broader overview of surgical cancer care, see our guide to oncology treatments in Turkey.
Robotic Prostatectomy in Turkey: how it works
- 1Send your photos and questions
Free and without obligation: tell us what you want to change and send a few photos — by form or WhatsApp.
- 2Get a written plan and price
A surgeon reviews your case and you receive a personal plan with the price, usually within 24 hours. Compare hospitals; nothing is paid in advance.
- 3Travel, surgery and aftercare
Airport pick-up, examination, surgery and check-ups in Istanbul, then follow-up with your surgeon after you fly home.
- Within about 2 hours
A coordinator replies in your language by WhatsApp or e-mail.
- Within 24 hours
A surgeon reviews your photos and you receive a written plan with the surgeon's name and the price.
- You decide
Ask anything and take your time — nothing is paid in advance.
Why plan Robotic Prostatectomy in Turkey with Treat Journey?
- Free for patients
Searching, comparing and requesting quotes costs nothing. You pay the hospital directly, at the price in your written quote — never a pre-payment to us.
- Real hospital prices, published
Every price on this page is the hospital's own price for international patients, shown live in your currency, with what the package includes.
- A named surgeon and a written plan
Your quote names the surgeon and the hospital and lists exactly what is included — no anonymous packages.
- Licensed hospitals only
We list licensed hospitals with an international patient department; accreditations such as JCI are shown on each hospital page.
- Honest reviews
We show real patient reviews, including Google reviews and critical ones, and we never invent ratings.
- Support before, during and after
A coordinator in your language answers within hours, arranges transfers and an interpreter, and stays in touch after you fly home.
How is robotic-assisted radical prostatectomy performed?
The operation is carried out under general anaesthesia and generally requires between two and four hours to complete. The surgical sequence follows structured surgical steps:
- Patient positioning and port placement: The patient is positioned in a steep Trendelenburg position (tilted head-down) so that the bowel shifts upward away from the deep pelvis. Carbon dioxide gas is gently introduced to create a clear working space, and five or six small trocars (5 mm to 12 mm) are placed across the lower abdomen.
- Console docking: The robotic cart is positioned beside the operating table, and mechanical arms holding the camera and multi-jointed EndoWrist instruments are docked onto the trocars.
- Bladder mobilisation and prostate dissection: Sitting at the console, the surgeon views the pelvic anatomy under ten- to fifteen-fold stereoscopic 3D magnification. The bladder is freed from the anterior abdominal wall, and the junction between the bladder neck and prostate is carefully transected.
- Nerve-sparing dissection: If diagnostic staging indicates the cancer is confined within the gland capsule, the surgeon performs nerve-sparing dissection. Magnified visual feedback allows delicate separation of the cavernosal nerve bundles running along the lateral borders of the prostate without tearing or thermal damage.
- Seminal vesicle and lymph node excision: The seminal vesicles and vas deferens are dissected free. In intermediate- and high-risk cases, a bilateral pelvic lymph node dissection is performed to check for microscopic nodal spread.
- Urethrovesical anastomosis and closure: After the prostate is detached, it is placed in an impermeable retrieval bag. The surgeon reconstructs the urinary tract by suturing the bladder neck directly to the urethra over a temporary Foley catheter. The prostate specimen is retrieved through an enlarged port incision, and the small skin cuts are sutured.
Does robotic prostatectomy work? Oncological outcomes and evidence
Extensive clinical evidence confirms that robot-assisted radical prostatectomy is an effective curative treatment for localized prostate cancer. Guidelines from the European Association of Urology (EAU), the American Urological Association (AUA), and the British Association of Urological Surgeons (BAUS) recognise robotic surgery as an established standard alongside open surgery and external beam radiotherapy.
In terms of cancer eradication, the primary benchmark is achieving negative surgical margins (meaning no cancer cells are present at the outer edge of the excised tissue) and maintaining an undetectable prostate-specific antigen (PSA) level post-operatively (typically defined as less than 0.1 or 0.2 ng/mL). Large multicentre studies indicate that when tumours are organ-confined, cancer-free survival rates at ten years exceed 90%. Compared with traditional open surgery, robotic instrumentation does not change baseline cancer biology, but its high-definition 3D visualization and wristed articulation reduce intraoperative blood loss, lower transfusion rates, and shorten hospital stay. Continence recovery and sexual potency recovery vary significantly with patient age, baseline function, tumour location, and whether bilateral nerve preservation was oncologically safe.
Robotic prostatectomy cost in Turkey compared with the UK, US and Germany
Understanding the financial aspects of surgery abroad helps patients plan realistically. The table below presents approximate cost ranges for robotic radical prostatectomy across different healthcare systems. These figures reflect typical comprehensive self-pay treatment ranges rather than hospital quotes.
| Country | Approximate cost range |
|---|---|
| Turkey | €7,000 – €14,000 |
| United Kingdom | €14,000 – €26,000 |
| United States | €22,000 – €48,000 |
| Germany | €13,000 – €24,000 |
The total robotic prostatectomy price is influenced by several variables: the operating surgeon's uro-oncological experience, whether pelvic lymphadenectomy is required, the type of hospital room and length of inpatient admission (usually two to four nights), pathology testing of the surgical margins and lymph nodes, and any necessary intensive care monitoring. In Turkey, international packages frequently bundle pre-operative blood work, multi-parametric MRI or PSMA PET-CT scan review, the robotic operating theatre fees, surgeon and anaesthetist fees, hospital stay, post-discharge medication, catheter supplies, and local transfer services. Patients seeking an itemised breakdown for their specific clinical stage can request a free quote before travelling.
Robotic prostatectomy compared with open surgery, laparoscopy and radiotherapy
When diagnosed with localised prostate cancer, patients frequently weigh robotic prostatectomy against traditional surgical approaches and non-surgical radiation options. Each modality presents distinct technical profiles and clinical trade-offs.
| Approach | Best suited to | Typical limits |
|---|---|---|
| Robotic prostatectomy (RARP) | Localised prostate cancer where nerve-sparing and precision dissection are planned | Requires dedicated robotic console and specialized surgical team; higher equipment cost |
| Open radical prostatectomy | Complex pelvic anatomy or centres without robotic infrastructure | Larger abdominal incision, higher intraoperative blood loss and longer hospital stay |
| Radiotherapy (EBRT + ADT) | Patients unsuitable for major surgery, older individuals or locally advanced disease | Does not excise the tumour tissue; potential bowel and bladder radiation side effects |
Open retropubic prostatectomy requires a midline lower abdominal incision of 10 to 15 cm. While cancer control rates between skilled open and robotic surgeons remain equivalent, robotic procedures consistently demonstrate less blood loss, lower infection rates, and quicker return of basic mobility. Conventional (non-robotic) laparoscopy utilizes rigid straight instruments without wristed motion, demanding steeper learning curves in deep pelvic spaces. External beam radiotherapy coupled with hormone therapy avoids surgery entirely, making it suitable for men with significant cardiac or respiratory risks, though it carries risks of radiation-induced cystitis or proctitis.
Who is an appropriate candidate for robotic prostate surgery?
Determining whether a patient is a suitable candidate for robot-assisted surgery depends on thorough oncological staging, general medical fitness, and individual preferences:
- Suitable candidates: Men diagnosed with biopsy-confirmed, clinically localised prostate cancer (stages T1c to T2, and select T3a cases) who have an anticipated life expectancy of at least 10 years and are fit for general anaesthesia. Patients seeking definitive surgical removal with complete pathological staging of the tumour and pelvic lymph nodes are typical candidates.
- Less suitable or unsuitable candidates: Men with distant metastases (bone or distant organ spread), severe cardiopulmonary conditions that preclude prolonged steep Trendelenburg positioning, uncontrolled bleeding disorders, or prior major pelvic surgery that has resulted in dense fibrotic adhesions. Patients with higher-risk or metastatic disease may require multimodal management within specialised oncology treatments in Turkey.
What do before and after outcomes mean in prostate cancer surgery?
In surgical oncology, evaluating robotic prostatectomy before and after outcomes focuses on therapeutic and functional benchmarks rather than cosmetic changes. Clinical teams monitor three core parameters:
1. Oncological eradication: Prior to surgery, a patient presents with an elevated PSA and biopsy-proven malignancy. Six to eight weeks post-operatively, blood testing should show an undetectable PSA (below 0.1 ng/mL), confirming that all functioning prostate tissue has been excised. Formal pathology reports evaluate margin status to verify whether the tumour was fully enclosed.
2. Continence restoration: Immediately following catheter removal, virtually all men experience temporary stress urinary incontinence (leakage during coughing, laughing, or standing). With structured pelvic floor muscle exercises (Kegel training), continence improves steadily: historical registry data indicate that 70% to 90% of men regain good urinary control (using zero to one security pad per day) by six to twelve months.
3. Potency recovery: Erectile function recovery is gradual and depends heavily on pre-existing sexual health, patient age, and whether bilateral nerve preservation was possible. Nerve bundles bruised by surgical traction can take 12 to 24 months to regenerate, often supported by rehabilitation protocols including PDE5 inhibitors.
Travel to Turkey and robotic prostatectomy recovery milestones
Travelling abroad for major urological surgery requires structured scheduling. The typical robotic prostatectomy recovery timeline involves specific medical milestones:
- Pre-operative days (Days 1–2): In-person consultation with the uro-oncologist and anaesthetist in Istanbul or Ankara. Pre-operative blood panels, electrocardiograms, chest imaging, and review of pelvic multi-parametric MRI or PSMA PET-CT scans are completed.
- Surgery and hospital admission (Days 3–6): Following the procedure, the patient stays in the hospital for two to four nights. Nurses assist with early walking within 24 hours to prevent venous thrombosis. A temporary Foley catheter remains in place to divert urine and allow the urethrovesical junction to heal.
- Outpatient recovery and catheter removal (Days 7–10): The patient stays in a nearby hotel for resting. Around Day 7 to 10, the patient attends the hospital clinic for wound inspection and catheter removal. Once spontaneous urination is confirmed, clearance for the return flight is issued. Learn more about travel scheduling and companion planning on our page explaining how it works.
- Home recovery (Weeks 3–12): Light daily activities and remote desk work can resume around week three to four. Heavy lifting (greater than 5 kg) and vigorous sports must be avoided for six weeks to prevent incisional hernias. First post-operative PSA blood testing is performed at six to eight weeks.
Potential risks and complications of robotic prostatectomy
Robot-assisted laparoscopic prostatectomy is major pelvic surgery and involves potential risks. Reliable guidance from healthcare authorities such as the NHS, the British Association of Urological Surgeons (BAUS), and the European Association of Urology (EAU) outlines known potential complications:
- Urinary incontinence: Temporary leakage is common after catheter removal. Persistent long-term incontinence requiring permanent pads occurs in approximately 2% to 5% of patients.
- Erectile dysfunction: Temporary or permanent loss of natural erections occurs in 30% to 70% of men, strongly correlated with patient age, baseline erectile rigidity, and whether nerve-sparing was technically feasible.
- Bleeding and transfusion: Intraoperative blood loss with robotic surgery is typically low (under 200–300 mL), but substantial haemorrhage requiring blood transfusion occurs in fewer than 2% of cases.
- Infection and fluid leakage: Urinary tract infection, wound infection at port sites, or anastomotic urine leakage at the bladder-urethra junction requiring prolonged catheter drainage.
- General surgical risks: Deep vein thrombosis (DVT), pulmonary embolism, pelvic lymphocele (fluid collection from lymph node removal), bowel injury (under 1%), or reactions to general anaesthesia.
How to select a surgical oncology centre and questions to ask
Selecting an accredited hospital and a dedicated uro-oncologist is essential when undertaking robotic prostatectomy Turkey programmes. Patients should confirm that the treating hospital possesses international accreditation (such as JCI or ISO), an active multidisciplinary tumour board (MDT), a 24-hour intensive care unit, and a high-volume robotic surgical theatre. Review our overview of how it works to understand pre-operative file reviews and hospital arrangements. You can submit your pathology reports and MRI scans through our free quote form for an initial surgical assessment.
Key red flags to avoid include clinics that quote fixed prices without reviewing your PSA history and biopsy pathology, sales facilitators who cannot name your specific operating surgeon, promises of immediate continence or guaranteed potency, and facilities without on-site emergency or intensive care support.
Essential questions to ask your surgical team:
- How many robot-assisted radical prostatectomies has the operating surgeon performed as primary console surgeon?
- Will my biopsy pathology and MRI scans be reviewed in a multidisciplinary oncology tumour board before surgery?
- Based on my cancer stage and Gleason score, is unilateral or bilateral nerve-sparing oncologically safe?
- What is your centre's specific protocol for urinary catheter removal, and how many days will the catheter remain?
- What immediate medical assistance is provided if I experience urinary retention or fever after hospital discharge?
- How will my follow-up PSA test results and post-operative pathology reports be coordinated with my physician at home?
Frequently asked questions
Robotic prostatectomy, or robot-assisted laparoscopic radical prostatectomy, is a minimally invasive surgical procedure that removes the entire prostate gland and seminal vesicles to treat localized prostate cancer. The surgeon controls micro-instruments and a high-definition 3D camera from a robotic console, allowing precise dissection within the narrow male pelvis while preserving surrounding neurovascular bundles.
Yes. Major urological registries, including the British Association of Urological Surgeons and European Association of Urology, demonstrate excellent long-term oncological control for localized prostate cancer. Following successful surgery, blood levels of prostate-specific antigen typically drop to undetectable amounts. Long-term disease control depends on cancer stage, Gleason grade and achieving clear surgical margins.
In Turkey, robotic prostatectomy typically ranges between €7,000 and €14,000, compared with €14,000 to €26,000 in the UK and higher in the US. The price varies according to hospital stay duration, intensive care observation, pelvic lymph node dissection requirements and pre-operative staging investigations. Hospitals confirm specific pricing through individual written medical quotations.
Unlike cosmetic procedures, prostatectomy before and after refers to clinical and functional parameters rather than visual appearances. Key measures include reducing prostate-specific antigen from elevated pre-operative levels to undetectable baseline measurements, regaining urinary continence across three to twelve months, and gradual recovery of erectile function when nerve-sparing techniques are clinically appropriate.
Hospital recovery lasts two to four days, with a urinary catheter remaining in place for seven to fourteen days to protect healing tissue. Most men walk comfortably within 24 hours, resume light daily routines after two weeks, and return to non-strenuous desk work within three to four weeks, with full pelvic floor strengthening continuing over months.
Because the operation uses five or six small keyhole incisions rather than a long abdominal cut, post-operative pain is typically moderate. Patients experience abdominal tightness, mild bruising, and temporary discomfort from the urinary catheter or laparoscopic gas. Discomfort is usually managed effectively with standard analgesics during hospital stay and initial recovery days.
For organ-confined prostate cancer with negative surgical margins, surgical removal provides permanent local tumour eradication. Patients monitor disease status through regular post-operative blood tests measuring prostate-specific antigen over ten to fifteen years. If microscopic cancer cells extended beyond the prostate, secondary radiotherapy or hormonal therapy can be administered.
Robot-assisted prostatectomy has an established safety profile when conducted by experienced urological surgeons in accredited acute hospitals. Compared with open surgery, it involves lower intraoperative blood loss and lower transfusion rates. As with any major pelvic procedure, risks include temporary urinary incontinence, erectile dysfunction, bleeding, infection, and rare vascular injury.
Neither treatment is universally superior; both achieve comparable long-term cancer survival for localized prostate cancer. Surgery removes the gland entirely, provides precise pathological tumour staging, and keeps radiation as a backup treatment if required. Radiotherapy avoids surgical incisions and general anaesthesia but may carry different long-term urinary and rectal side effects.
International patients usually stay in Turkey for eight to ten nights. This schedule accommodates pre-operative anaesthetic evaluations and scans, two to four nights in the hospital following surgery, and an outpatient review for wound inspection and urinary catheter removal before safe clearance for international flight travel.